Pharmacy supervision reform in the UK: what changed for dispensing, and what it means for telehealth

For most of pharmacy's modern history, UK law assumed a pharmacist had to be on site and personally overseeing every sale or dispensing step. That assumption was reworked as part of a long-running reform to modernise supervision rules that predate remote consultations, courier dispatch, and dispensing hubs serving thousands of patients a week. The legal change is narrow. What it means in practice for a dispensing pharmacy, and for the brands and clinics relying on one, is the part worth understanding properly.

Why supervision needed reforming

The supervision requirements in the Medicines Act 1968 and the Human Medicines Regulations 2012 were written for a model of pharmacy that barely resembles how a lot of dispensing happens today. They assumed one pharmacist, one counter, one continuous physical presence, with every sale and every dispensing step happening under that person's direct eye.

Bodies including the GPhC and the Royal Pharmaceutical Society had flagged for years that this created friction without adding safety: a pharmacist tied to being physically present for routine, low-risk tasks that a trained and registered pharmacy technician could reasonably handle under a clear governance framework. That gap fed into the joint government and regulator programme generally known as Rebalancing Medicines Legislation and Pharmacy Regulation, which is where this reform originates.

What actually changed

Two changes matter most for a dispensing operation. First, a pharmacist can authorise a registered pharmacy technician to carry out the final accuracy check on a dispensed prescription, rather than that check always falling to the pharmacist personally. Second, the sale and supply of pharmacy medicines, and the supply of prescription-only medicines against a valid prescription, can now take place under a pharmacist's supervision without that pharmacist being physically present in the building at every moment, provided the pharmacy has assessed the risk and built in appropriate safeguards.

Neither change removes the pharmacist from the picture. It changes where they need to physically be while the underlying professional accountability, the kind set out for a superintendent pharmacist, stays exactly where it was. For background on how a dispensing step fits into the wider telehealth workflow, see our explainer on what dispensing actually involves.

What has not changed

The responsible pharmacist regime is still in force: every registered pharmacy premises needs a named responsible pharmacist in charge during opening hours, and that person is still professionally accountable for what happens under their watch. The superintendent pharmacist's overall responsibility for the pharmacy's operation is untouched by this reform.

The clinical decision behind a prescription, the part a prescriber makes about whether a medicine is appropriate for a particular patient, was never part of the supervision rules being changed and remains exactly as it was. Controlled drugs are also unaffected: safe custody, running balances, and the additional checks around controlled-drug supply sit outside this reform entirely, and prescriber discretion applies throughout.

The practical shift inside a dispensing pharmacy

On the ground, the change shows up less as a legal event and more as a set of operational decisions a pharmacy has to make and document. A pharmacy that wants to use the new flexibility typically needs to work through:

• A written risk assessment covering which tasks can run without the pharmacist physically present, and which cannot
• Clear standard operating procedures defining exactly when a technician is authorised to sign off a final accuracy check
• An escalation pathway for anything a technician is unsure about, with the pharmacist reachable and genuinely able to intervene
• Training and competency records for every technician taking on delegated tasks, kept current rather than a one-off sign-off
• A way of evidencing all of the above to an inspector, since none of it is worth much if it only lives in someone's memory

For most of the operators we work with, that last point is where the real work sits. See our broader guide to writing SOPs that actually hold up for how this fits into a wider operating framework.

What GPhC inspectors are actually looking for

The GPhC has been clear that the reform is not a licence to run a pharmacy with looser standards, and inspectors are applying that view. The standards for registered pharmacies still apply in full: governance, risk management, and staff competence are assessed exactly as before, just against a slightly wider set of permitted working models.

What tends to come up at inspection is whether a pharmacy can show its reasoning, not just its outcome. A pharmacy that decided supervision could safely move to a remote model for certain tasks needs to be able to explain why, point to the risk assessment behind it, and show the training records for anyone acting under delegated authority. Our guide to preparing for a GPhC inspection covers the evidence base inspectors expect to see across most standards, and this reform simply adds one more area where that evidence has to exist.

The reform moves where a pharmacist has to stand. It does not move the accountability that follows them.

Questions to ask a dispensing partner

If your clinic or brand relies on a third-party dispensing pharmacy, this reform is worth raising directly rather than assuming it has been handled somewhere upstream. A short, direct conversation usually reveals how seriously a partner has taken it:

1. Has the pharmacy formally adopted any of the new supervision flexibilities, or is it operating exactly as before
2. Where a pharmacy technician now completes a final accuracy check, what training and sign-off sits behind that authorisation
3. What does the escalation path look like when a technician working without a pharmacist physically present has a concern
4. How is this documented, and would it survive being asked for on the day of an inspection
5. Has the responsible pharmacist and superintendent pharmacist reviewed and signed off the approach

A partner that answers these questions cleanly and specifically is a good sign. Vague reassurance is not. Our guide to choosing a dispensing partner covers the wider due-diligence list this sits inside.

Where this leaves clinics and brands working with PExpo

PExpo sits between clinics and brands and the regulated dispensing layer, and that layer is where this reform actually lives. Our dispensing partners operate under the same GPhC standards, the same superintendent pharmacist accountability, and the same responsible pharmacist regime as any other UK registered pharmacy, reform or no reform.

What changes for a brand or clinic working with PExpo is not the accountability chain, which stays fully intact, but the operational detail worth asking about when comparing dispensing setups. If you are evaluating whether a current or prospective partner has actually done the work behind any new flexibility they have adopted, that is a conversation we are happy to have directly.

Supervision reform is a narrow legal change with a wide set of operational implications, and the gap between the two is exactly where due diligence matters. Whether you are running your own dispensing or relying on a partner, the questions to ask are the same: what changed, what evidence backs it up, and who signs off on it. For related reading, see how to find a UK dispensing partner, our roundup of dispensing partners operating in 2026, and our pricing overview if you are comparing models.

Frequently asked questions